Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 74 Colorectal Neoplasms 43 Rectal Neoplasms 42 Stomach Neoplasms 39 Triple Negative Breast Neoplasms 30 Neoplasm Metastasis 19 Esophageal Neoplasms 16 Colonic Neoplasms 16 Neoplasms 13 Pancreatic Neoplasms 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Nasopharyngeal Carcinoma 11 Adenocarcinoma 11 Biliary Tract Neoplasms 10 Adenocarcinoma Of Esophagus 9 Cholangiocarcinoma 7 Locally Advanced Rectal Cancer 6 Esophageal Squamous Cell Carcinoma 6 Brain Neoplasms 6 Anus Neoplasms 6 Recurrence 5 Neuroendocrine Tumors 5 Gastrointestinal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 HER2-positive Breast Cancer 4 Colorectal Cancer Metastatic 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Pathologic Complete Response 3

Interventions

Cisplatin 7 Gemcitabine 6 pembrolizumab 4 Radiotherapy, Intensity-Modulated 4 toripalimab 2 Bevacizumab 2 tocilizumab 1 tislelizumab 1 spartalizumab 1 penpulimab 1 atezolizumab 1 Vitamin D 1 Tablets 1 Surveys and Questionnaires 1 Phantoms, Imaging 1 Oral Hygiene 1 Observation 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Immunohistochemistry 1 Immunoglobulin G 1 Fluorouracil 1 Disulfides 1 Dexamethasone 1 Chemoradiotherapy 1 Cetuximab 1 Carboplatin 1 Capecitabine 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Neoplasms × Capecitabine × 1 year × Clear all

NCT05807880 2026-01-23

ALTER-HN005

Sun Yat-sen University

Phase 2 Active not recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡